Market Place
Sourcing Support
Akebia Therapeutics Reports Q2 2024 Results And Business Highlights
08 Aug 2024 //
PR NEWSWIRE
Akebia Announces Positive Top-Line Results of Phase 4 IMPACT Study of Auryxia
29 Jun 2023 //
PR NEWSWIRE
Enforcement Report - Week of February 24, 2021
24 Feb 2021 //
FDA
Enforcement Report - Week of December 30, 2020
30 Dec 2020 //
FDA
Enforcement Report - Week of July 22, 2020
22 Jul 2020 //
FDA
Akebia Announces Data on Different Dosing Regimens of Ferric Citrate
10 Jun 2020 //
PRNEWSWIRE
Akebia Announces Collaboration Partner`s Submission of sNDA for Use of Riona®
18 May 2020 //
PRNEWSWIRE
Akebia Files Lawsuit Against CMS for 2018 Action
15 Oct 2019 //
BUSINESSWIRE
Auryxia (Ferric Citrate) : Keryx Biopharma vs. Mylan Pharma
18 Mar 2019 //
PATENT LITIGATION
Auryxia (Ferric Citrate) : Keryx Biopharmaceuticals vs. Teva Pharmaceuticals
20 Dec 2018 //
PATENT LITIGATION
Akebia Therapeutics, Keryx Biopharms Announce Chairperson for Combined Company
16 Nov 2018 //
BUSINESSWIRE
Akebia Therapeutics and Keryx Biopharmaceuticals merge, creating a $1bn company
02 Jul 2018 //
HEALTHCARE GLOBAL
WeissLaw LLP Investigates Keryx Biopharmaceuticals Inc.
29 Jun 2018 //
PR NEWSWIRE
Akebia, Keryx to merge, creating kidney disease specialist
29 Jun 2018 //
FIERCE BIOTECH
Keryx Announces Data from an Investigator Sponsored Trial of Ferric Citrate
25 May 2018 //
PRESS RELEASE
Keryx Announces that Auryxia® is Now on Formulary Medicare Part D Plans
01 May 2018 //
PRESS RELEASE
Keryx Announces Pub of Data from the Phase 3 Trial of Auryxia® ferric citrate
04 Apr 2018 //
PRESS RELEASE
Keryx hires Siegfried to make Auryxia API
05 Jan 2018 //
IN PHARMATECHNOLOGIST
Enforcement Report - Week of January 3, 2018
03 Jan 2018 //
FDA
Keryx looks for Auryxia boost with iron deficiency launch
08 Nov 2017 //
FIERCE PHARMA
USFDA Approves Auryxia® Tablets as Treatment for People Iron Deficiency Anemia
07 Nov 2017 //
PRESS RELEASE
Keryx: Patheon and Norwich sites will ensure supply of iron-based Auryxia
07 Mar 2017 //
IN PHARMATECHNOLOGIST
Aptevo says production issues for hemophilia B treatment Ixinity appear resolved
04 Jan 2017 //
FIERCE PHARMA
Keryx (KERX) Shares Fall After Manufacturing of Drug is Halted
03 Aug 2016 //
BIOSPACE
Keryx anemia med Auryxia trounces placebo in study aimed at big new use
30 Mar 2016 //
FIERCE PHARMA MARKETING
Keryx`s Fexeric approved in EU for Hyperphosphatemia
02 Oct 2015 //
EMA
EU clears Keryx` hyperphosphataemia drug
24 Sep 2015 //
PHARMA TIMES
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.